Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 116

Results For "UP"

7661 News Found

Zoho to invest US $ 5 million in Voxelgrids, a startup that builds MRI scanners
Digitisation | September 09, 2021

Zoho to invest US $ 5 million in Voxelgrids, a startup that builds MRI scanners

Over 70 per cent of the world’s population have no access to MRI scanners and the situation is not that encouraging in India where there are only 0.4 MRI scanners per thousand people


TCS leads in Life Sciences operations services: Everest group
Digitisation | September 08, 2021

TCS leads in Life Sciences operations services: Everest group

TCS provides clinical research services such as clinical data management, regulatory affairs, pharmacovigilance, risk-based monitoring, biostatistics and programming, medical writing, medical affairs and medico marketing, and health economics and outcomes research


Panacea Biotech supplies 1st shipment of the second component of Sputnik V vaccine
News | September 07, 2021

Panacea Biotech supplies 1st shipment of the second component of Sputnik V vaccine

The batch will be distributed in India through a partner of RDIF and Panacea Biotec - Dr. Reddy's Laboratories


TB Alliance partners with Lupin for non-exclusive anti-TB drug
Policy | September 06, 2021

TB Alliance partners with Lupin for non-exclusive anti-TB drug

According to WHO, over 1.5 million people died of TB in 2020


Two major hospitals in Gujarat announce tie-up
Healthcare | September 01, 2021

Two major hospitals in Gujarat announce tie-up

Aashka Hospitals has entered into a non-binding agreement for its proposed tie-up with Vaidehi—Backbone hospital, Rajkot


Positive results from Pfizer’s Phase 3 trail comparing efficacy of abrocitinib and dupilumab
Drug Approval | September 01, 2021

Positive results from Pfizer’s Phase 3 trail comparing efficacy of abrocitinib and dupilumab

JADE DARE trial met co-primary and key secondary endpoints and demonstrated a safety profile consistent with previous studies for moderate to severe atopic dermatitis


Sanofi’s Dupixent pivotal trial meets all primary and secondary endpoints for treatment of atopic dermatitis
Biotech | August 31, 2021

Sanofi’s Dupixent pivotal trial meets all primary and secondary endpoints for treatment of atopic dermatitis

Results reinforce the well-established safety profile of Dupixent - the first-ever biologic medicine for atopic dermatitis currently approved for patients as young 6 years old


Max Healthcare to set up a 500-bed capacity hospital in Delhi
Healthcare | August 28, 2021

Max Healthcare to set up a 500-bed capacity hospital in Delhi

This facility will integrate with existing Max hospitals and create a 2,300-bed contiguous medical hub spread over 23 acres. The first phase is to be ready by 2024


Encision signs supply agreement with Auris Health
Healthcare | August 25, 2021

Encision signs supply agreement with Auris Health

The company pioneered the development and deployment of Active Electrode Monitoring, AEM technology, to eliminate dangerous stray energy burns during minimally invasive procedures


Govt to offer incentives to support 75 start-ups in Tele-Medicine, AI and Digital Health
Startup | August 25, 2021

Govt to offer incentives to support 75 start-ups in Tele-Medicine, AI and Digital Health

The aim is to give a fillip to R&D in the health sector to face the Covid-19 challenge